Dose-dependent Absorption
Dose-dependent Absorption - Related Videos
01:24
Drug Toxicity: Dose-Dependent Reactions
0 Views •
2026
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:23
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
0 Views •
2025
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model. A study on guinea pigs examined the...
02:46
Visualizing Dose-Dependent Spike Protein Uptake with Quantum Dot Conjugates
0 Views •
2026
Source: Tran, B. N., et. al. High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells. J. Vis. Exp. (2022)This video demonstrates the use of quantum dot–conjugated spike protein (QD-Spike) to visualize dose-dependent viral entry in ACE2-GFP–expressing cells. Confocal imaging captures the internalization of QD-Spike via receptor-mediated endocytosis, modeling early coronavirus entry.
01:19
Drug Absorption: Factors Affecting GI Absorption
0 Views •
2023
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate. In...
01:25
Carbohydrate Absorption
0 Views •
2025
Carbohydrates are essential macronutrients that serve as the body's primary energy source. Their digestion begins in the mouth, where salivary amylase partially breaks down complex carbohydrates such as starch into smaller oligosaccharides. This mechanical and enzymatic activity prepares carbohydrates for further processing in the gastrointestinal tract. After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
FAQs
At higher doses, an absorption step can become a limiting factor rather than increasing in proportion to the administered amount. Intestinal dissolution, movement across membranes, or carrier-mediated uptake may reach a capacity where additional drug cannot be processed at the same rate. Consequently, systemic exposure may rise less than expected from the dose increase, complicating concentration interpretation.
Intestinal dissolution can determine how much drug is available for subsequent uptake. If a larger dose does not dissolve sufficiently or rapidly enough, the amount presented for absorption may fail to increase proportionally. This creates a dose-related change in bioavailability and can make concentration-time results appear nonlinear, even when the administered dose was accurately measured.
These pathways can limit absorption through different mechanisms. Membrane passage may constrain movement into the systemic circulation, whereas a carrier-mediated process can become saturated as available uptake sites are occupied. Once capacity is approached, increasing the dose may produce a smaller incremental increase in absorbed drug. Distinguishing these possibilities helps explain the shape of exposure across doses.
Dose proportionality matters because systemic concentrations may not track the prescribed dose in a predictable way. A larger dose can produce unexpectedly high exposure in some situations or a smaller-than-expected increase in others, depending on the limiting absorption process. Recognizing this pattern supports interpretation of concentration-time data and helps identify ranges where toxicity or reduced therapeutic benefit may become concerns.
Investigators compare several administered doses with the resulting systemic concentration-time profiles. They examine whether exposure and bioavailability increase in proportion to dose or show a changing relationship across the tested range. This assessment links the measured concentrations to the dose given and can reveal absorption limitations that would be missed if only one dose were studied.
Findings can indicate whether a formulation delivers drug consistently as the dose changes and whether a planned dose range is likely to alter exposure disproportionately. Clinical teams can use that information when selecting safer doses, refining formulations, and anticipating differences in patient response across treatment levels. The resulting analysis supports more informed benefit-risk decisions during development.